Dataset Information

Microscale Parallel Synthesis of Acylated Aminotriazoles Enabling the Development of Factor XIIa and Thrombin Inhibitors.

ABSTRACT: Herein we report a microscale parallel synthetic approach allowing for rapid access to libraries of N-acylated aminotriazoles and screening of their inhibitory activity against factor XIIa (FXIIa) and thrombin, which are targets for antithrombotic drugs. This approach, in combination with post-screening structure optimization, yielded a potent 7 nM inhibitor of FXIIa and a 25 nM thrombin inhibitor; both compounds showed no inhibition of the other tested serine proteases. Selected N-acylated aminotriazoles exhibited anticoagulant properties in vitro influencing the intrinsic blood coagulation pathway, but not extrinsic coagulation. Mechanistic studies of FXIIa inhibition suggested that synthesized N-acylated aminotriazoles are covalent inhibitors of FXIIa. These synthesized compounds may serve as a promising starting point for the development of novel antithrombotic drugs.

SUBMITTER: Platte S

PROVIDER: S-EPMC9292294 | biostudies-literature | 2021 Dec

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Microscale Parallel Synthesis of Acylated Aminotriazoles Enabling the Development of Factor XIIa and Thrombin Inhibitors.

Platte Simon S Korff Marvin M Imberg Lukas L Balicioglu Ilker I Erbacher Catharina C Will Jonas M JM Daniliuc Constantin G CG Karst Uwe U Kalinin Dmitrii V DV

ChemMedChem 20210804 24

Herein we report a microscale parallel synthetic approach allowing for rapid access to libraries of N-acylated aminotriazoles and screening of their inhibitory activity against factor XIIa (FXIIa) and thrombin, which are targets for antithrombotic drugs. This approach, in combination with post-screening structure optimization, yielded a potent 7 nM inhibitor of FXIIa and a 25 nM thrombin inhibitor; both compounds showed no inhibition of the other tested serine proteases. Selected N-acylated amin ...[more]

PMID: 34278727

Dataset Information

Microscale Parallel Synthesis of Acylated Aminotriazoles Enabling the Development of Factor XIIa and Thrombin Inhibitors.

Publications

Microscale Parallel Synthesis of Acylated Aminotriazoles Enabling the Development of Factor XIIa and Thrombin Inhibitors.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets

Similar Datasets

Amide-functionalized 1,2,4-Triazol-5-amines as Covalent Inhibitors of Blood Coagulation Factor XIIa and Thrombin.
| S-EPMC9745896 | biostudies-literature

New Blood Coagulation Factor XIIa Inhibitors: Molecular Modeling, Synthesis, and Experimental Confirmation.
| S-EPMC8876603 | biostudies-literature

Factor XI homodimer structure is essential for normal proteolytic activation by factor XIIa, thrombin, and factor XIa.
| S-EPMC2441546 | biostudies-literature

Structures of human plasma β-factor XIIa cocrystallized with potent inhibitors.
| S-EPMC5851424 | biostudies-literature

Supercomputer Search for the New Inhibitors of the Coagulation Factor XIIa
| S-EPMC9362379 | biostudies-literature

New Triazole-Based Potent Inhibitors of Human Factor XIIa as Anticoagulants.
| S-EPMC10918664 | biostudies-literature

High-Throughput Docking and Molecular Dynamics Simulations towards the Identification of Potential Inhibitors against Human Coagulation Factor XIIa.
| S-EPMC7261338 | biostudies-literature

Enabling synthesis in fragment-based drug discovery (FBDD): microscale high-throughput optimisation of the medicinal chemist's toolbox reactions.
| S-EPMC10718589 | biostudies-literature

First synthesis of acylated nitrocyclopropanes.
| S-EPMC10291240 | biostudies-literature